Aerosolized pentamidine in Pneumocystis carinii pneumonia
Related Experiment Video
Updated: Oct 6, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
A On1
1Department of Pharmacy Services, Hartford Hospital.
Abstract:
AP has been shown to be a promising alternative therapy to trimethroprim-sulfamethoxazole for the treatment and prevention of PCP in AIDS patients with fewer side effects than the systemic agents. More controlled clinical trials are still needed to establish the optimal dosage regimen for treatment and prevention of PCP. Clinicians should also be aware that disseminated disease caused by pneumocystis carinii involving organs other than the lung has been reported in patients treated with AP. The selection of an effective aerosol-delivery nebulizer is also very important to achieve high lung concentrations. The Respirgard II nebulizer is the only one currently approved by the FDA for use with AP. Fisoneb, an ultrasonic nebulizer is currently under investigation for approval.
Related Concept Videos
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Atypical Pneumonia
Cryptococcal Meningitis
Pneumonia I: Introduction

